A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma

Clinical trial NCT06157827 · RECRUITING

Trial details

NCT number: NCT06157827
Sponsor: Nanjing Leads Biolabs Co.,Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Neuroendocrine Carcinoma

Start date: 2023-12-08
Primary completion: 2026-12-28
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.